Bayesian Adaptive Enrichment Design for Continuous Biomarkers
Statistics in Medicine · 2025
DOI: 10.1002/sim.70262 ↗At a glance
Journal article in Statistics in Medicine, 2025. Written by Yue Tu and 3 co-authors. Institution: Department of Population and Public Health Sciences, University of Southern California, Los Angeles, California, USA. Major MEDLINE topics: Biomarkers, Randomized Controlled Trials as Topic, Research Design. Cited 1 times so far (Crossref); 14 references. The full text is freely available in PubMed Central. Funded by: NCI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (original language)
With the advent of precision medicine and targeted therapies in cancer, new challenges in the statistical design of clinical trials have naturally emerged. Most randomized clinical trial designs incorporating predictive biomarkers (those associated with treatment efficacy) assume biomarkers are dichotomous, or dichotomize naturally continuous biomarkers upfront, or find cut points mid‐way through the trial to classify patients as biomarker‐positive or biomarker‐negative. However, these practices ignore or discard information about continuous and possible nonlinear or non‐monotone prognostic or predictive effects. In this article, we propose a novel adaptive enrichment trial design to handle continuous biomarkers with any effect shape, including Bayesian marker‐adaptive randomization. We demonstrate that this design can correctly make marker‐specific trial decisions with high efficiency, resulting in improved performance and patient‐centered decisions compared to adaptive cut‐point selection approaches without adaptive randomization that further ignore or oversimplify true underlying marker relationships.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Population and Public Health Sciences, University of Southern California, Los Angeles, California, USA.
- Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- Children's Oncology Group, Monrovia, California, USA.
ORCID profiles: Lindsay A Renfro
Funding
- NCI NIH HHS
- NIH HHS
- National Institutes of Health
Cite
APA
Tu, Y., Liu, Y., Mack, W. J., & Renfro, L. A. (2025). Bayesian Adaptive Enrichment Design for Continuous Biomarkers. Statistics in Medicine. https://doi.org/10.1002/sim.70262
Vancouver
Tu Y, Liu Y, Mack WJ, Renfro LA. Bayesian Adaptive Enrichment Design for Continuous Biomarkers. Statistics in Medicine. 2025. doi:10.1002/sim.70262
BibTeX
@article{Tu2025,
author = {Tu, Yue and Liu, Yusha and Mack, Wendy J and Renfro, Lindsay A},
title = {Bayesian Adaptive Enrichment Design for Continuous Biomarkers},
journal = {Statistics in Medicine},
year = {2025},
doi = {10.1002/sim.70262}
}
EUVIMED